Evidence map›Paper›PMID 39215061›Full record

ArticleLeukemia2024

Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis.

Irene Pastor-Galán, Arturo Pereira, Eduardo Arellano-Rodrigo, Iván Martín, Adrián Mosquera-Orgueira, María-Teresa Gómez-Casares, Alberto Hernández-Sánchez, Francisca Ferrer-Marín, Elvira Mora, Patricia Velez and 24 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Irene Pastor-GalánHospital Clínico Universitario-INCLIVA, Valencia, Spain.
Arturo PereiraHospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Eduardo Arellano-RodrigoHospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. arellano@clinic.cat.ORCID http://orcid.org/0000-0001-6236-7826
Iván MartínHospital Clínico Universitario-INCLIVA, Valencia, Spain.
Adrián Mosquera-OrgueiraHospital Clínico Universitario, Santiago de Compostela, Spain.
María-Teresa Gómez-CasaresHospital Dr Negrín, Las Palmas de Gran Canaria, Spain.ORCID http://orcid.org/0000-0003-0505-5126
Alberto Hernández-SánchezHospital Universitario de Salamanca, Salamanca, Spain.ORCID http://orcid.org/0000-0002-6601-3096
Francisca Ferrer-MarínHospital Morales Meseguer, Universidad Católica San Antonio de Murcia, Centro de Investigación Biomédica en Red de Enfermedades Raras, Murcia, Spain.ORCID http://orcid.org/0000-0002-9520-3243
Elvira MoraHospital Universitario La Fe, Valencia, Spain.ORCID http://orcid.org/0000-0003-3361-8803
Patricia VelezHospital del Mar, Barcelona, Spain.
Rosa AyalaHospital Universitario 12 de Octubre, I+12, Complutense University, Centro de Investigación Biomédica en Red de Oncología, Madrid, Spain.
Anna AngonaHospital Josep Trueta, Institut Catalá d'Oncologia, Girona, Spain.
Natalia de Las HerasHospital Universitario de León, León, Spain.
Elena MagroHospital Príncipe de Asturias, Alcalá de Henares, Spain.
María-Isabel Mata-VázquezHospital Costa del Sol, Marbella, Spain.
María-Laura FoxVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Sonia González de VillambrosíaHospital Marqués de Valdecilla, Santander, Spain.
María-José RamírezHospital General, Jerez de la Frontera, Spain.
Ana GarcíaHospital Clínico Universitario, Valladolid, Spain.
Valentín García-GutiérrezHospital Ramón y Cajal, Universidad de Alcalá, Madrid, Spain.ORCID http://orcid.org/0000-0003-4752-0815
Amparo CáceresHospital Arnau de Vilanova, Valencia, Spain.
María-Antonia DuránHospital Son Espases, Mallorca, Spain.
María-Alicia SenínInstitut Catalá d'Oncologia, L'Hospitalet de Llobregat, Spain.
José-María RayaHospital Universitario de Canarias, Tenerife, Spain.
José Antonio GonzálezHospital Virgen del Puerto, Plasencia, Spain.
Beatriz CuevasHospital Universitario de Burgos, Burgos, Spain.ORCID http://orcid.org/0000-0001-7555-3361
Blanca XicoyHospital Germans Trias i Pujol, Institut Català d'Oncologia, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.
Marta GarroteHospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.ORCID http://orcid.org/0000-0001-8571-1466
Blanca FerrerHospital Clínico Universitario-INCLIVA, Valencia, Spain.ORCID http://orcid.org/0000-0001-9452-7310
Manuel Pérez-EncinasHospital Clínico Universitario, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0001-9943-4404
Jesús María Hernández-RivasHospital Universitario de Salamanca, Salamanca, Spain.
Beatriz BellosilloHospital del Mar, Barcelona, Spain.
Alberto Álvarez-LarránHospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Juan Carlos Hernández-BoludaHospital Clínico Universitario-INCLIVA, Valencia, Spain. hernandez_jca@gva.es.ORCID http://orcid.org/0000-0002-4289-3113

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.